Practice guideline on the prevention and treatment of central line associated bloodstream infection in 2025.
10.3760/cma.j.cn121430-20250301-00199
- Author:
CHINESE SOCIETY OF CRITICAL CARE MEDICINE
1
Author Information
1. Corresponding author: Chen Dechang, Department of Critical Care Medicine, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China, Email: chendechangsh@hotmail.com; Kang Yan, Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu 610044, Sichuan, China, Email: Kangyan@scu.edu.cn; Guan Xiangdong, Department of Critical Care Medicine, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong, China, Email: guanxd@mail.sysu.edu.cn.
- Publication Type:English Abstract
- MeSH:
Humans;
Catheter-Related Infections/therapy*;
Catheterization, Central Venous/adverse effects*;
Bacteremia/therapy*;
Intensive Care Units;
Cross Infection/prevention & control*
- From:
Chinese Critical Care Medicine
2025;37(3):193-220
- CountryChina
- Language:Chinese
-
Abstract:
Central line associated bloodstream infection (CLABSI) is the most severe complication of indwelling intravascular catheters and one of the most common causes of intensive care unit (ICU)- or hospital-acquired infections. Once CLABSI occurs, it significantly increases the risk of mortality, long of hospital stay, and healthcare economic burden. In recent years, multiple large-scale clinical studies on the diagnosis, treatment, and prevention of CLABSI have been completed, providing evidence-based medical support for related practices. Additionally, evolving global trends in antibiotic resistance epidemiology and the development of novel antimicrobial agents necessitate adjustments in clinical management strategies. Based on these developments, the Chinese Society of Critical Care Medicine has updated and revised the Guideline on the Prevention and Treatment of Intravascular Catheter-Related Infections (2007). This guideline was developed following the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system for evidence quality assessment. Guided by clinical questions, the working group initiated the process by defining key clinical issues, conducting literature searches, screening studies, performing meta-analyses, and synthesizing evidence-based findings to draft preliminary recommendations. These recommendations underwent iterative revisions through expert panel reviews, remote and in-person meetings, and two rounds of voting by the Standing Committee of the Chinese Society of Critical Care Medicine before finalization. The guideline comprises 52 recommendations, focusing on adult patients with central venous catheters in ICU. Key areas addressed include: selection of catheter insertion sites and techniques, catheter type and design, catheter management, prevention, diagnosis, and treatment of CLABSI. The guideline aims to provide ICU healthcare professionals with best practices for central line management, ensuring standardized clinical protocols for adult CLABSI.
